Advertisement

Topics

Bioniche Therapeutics Company Profile

21:45 EST 11th December 2018 | BioPortfolio

I'm pleased to welcome you to the Bioniche Life Sciences website. We hope your visit provides you with an informative view of the company, our goals, our science and our focus on innovation. In 2004, Bioniche achieved an important milestone: our 25th year in business. Today, we have an expanding global presence, a dedicated employee base, an experienced leadership team, and a product and technology mix that is exceptional

Location

P.O. Box 1570
Belleville,
Ontario
K8N 5J2
Canada

Contact

Phone: 613) 966-8058 or (800) 265-5464
Fax: (613) 966-4177
Email: rlevine@hfgcg.com


News Articles [697 Associated News Articles listed on BioPortfolio]

Bioniche: Graeme McRae on Bioniche`s Newly Discovered Cancer Killing Bacteria

In this episode of PharmaTelevision News Review, Fintan Walton talks with Graeme McRae, CEO at Bioniche. Filmed at BioChicago 2010 in Chicago, USA, they discuss: • Origins and focus of Bioniche •...

M&As this week: Nabriva Therapeutics, Sangamo Therapeutics, Ryboquin

Nabriva Therapeutics has completed the acquisition of Zavante Therapeutics for $97.5m. The acquisition will add the target company’s CONTEPO™ drug, which...Read More... The post M&As this we...

Roche’s Genentech agrees to buy Jecure Therapeutics

Based in San Diego of California, Jecure Therapeutics is engaged in the discovery of therapeutics to treat non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure Therapeutics president and CE...

HiFiBiO Therapeutics buys early-stage biotech firm H-Immune Therapeutics

The acquisition strengthens HiFiBiO Therapeutics’ strategic focus on identifying first-in-class targets for multiple immune cell types, as well as applying industry-leading technologies to develop d...

Small-Cap Snapshot: Galectin Therapeutics flies after receiving a patent for treating pulmonary fibrosis

Aquinox Pharmaceuticals, Summit Therapeutics and Global Blood Therapeutics are also making news

Deals and M&As this week: Pliant Therapeutics, MolMed, Modus Therapeutics

Pliant Therapeutics has raised $62m through a series B financing round from Cowen Healthcare Investments. The funding round also included participation...Read More... The post Deals and M&As thi...

iCo Therapeutics Announces Positive Clinical Outcome - Primary Endpoint Met in Phase 1 Oral Amphotericin B Study

Vancouver, British Columbia--(Newsfile Corp. - June 27, 2018) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company"), and its subsidiary iCo Therapeutics Australia Pty Ltd., to...

iCo Therapeutics Announces Positive Secondary Endpoint and Advancement into Later Stage Clinical Trials - Phase 1 Oral Amphotericin B

Vancouver, British Columbia--(Newsfile Corp. - July 16, 2018) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company"), and its subsidiary iCo Therapeutics Australia Pty Ltd., to...

PubMed Articles [457 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Eyes on New Product Development.

Clinical Trials [164 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1287 Associated Companies listed on BioPortfolio]

Bioniche Therapeutics

I'm pleased to welcome you to the Bioniche Life Sciences website. We hope your visit provides you with an informative view of the company, our goals, our science and our focus on innovation. In 2004, ...

Bioniche Pharma

Bioniche Pharma is a global manufacturer of injectable pharmaceutical products serving a variety of niche markets, including anaesthesiology, orthopedics, rheumatology, urology, and dermatology. An in...

Bioniche Animal Health USA, Inc.

Bioniche Animal Health was formed in 1979 as a privately owned company to develop vaccines and other pharmaceutical-based products for the preventative health management of animal diseases. Now a Divi...

Bioniche Inc

Bioniche Life Sciences Inc. is a fully integrated, Canadian biopharmaceutical company engaged in the research, development, production and commercialization of proprietary technologies for human and a...

Bioniche Life Sciences Inc.

More Information about "Bioniche Therapeutics" on BioPortfolio

We have published hundreds of Bioniche Therapeutics news stories on BioPortfolio along with dozens of Bioniche Therapeutics Clinical Trials and PubMed Articles about Bioniche Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bioniche Therapeutics Companies in our database. You can also find out about relevant Bioniche Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record